Alcoholism – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:13:02 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Alcoholism – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Cannabidiol for Reducing Alcohol Consumption in Patients with Alcohol Use Disorder https://clinicaltrials.eu/trial/study-on-cannabidiol-for-reducing-alcohol-consumption-in-patients-with-alcohol-use-disorder/ Wed, 29 Apr 2026 15:01:51 +0000 https://clinicaltrials.eu/trial/study-on-cannabidiol-for-reducing-alcohol-consumption-in-patients-with-alcohol-use-disorder/ This clinical trial is focused on studying the effects of Alcohol Use Disorder (AUD), a condition where individuals have difficulty controlling their alcohol consumption, leading to significant health and social problems. The study will explore the use of Cannabidiol (CBD), a chemical compound found in cannabis plants, as a potential treatment to help reduce alcohol consumption in individuals with AUD. Participants in the study will receive either CBD in the form of an oral solution or a placebo, which is a substance with no active medication.

The purpose of the study is to compare the reduction in alcohol drinking between those taking CBD and those taking the placebo. The study will last for a total of 16 weeks. During this time, participants will be asked to track their alcohol consumption and other health indicators. The study will begin with a period where participants’ current drinking habits are recorded, followed by the administration of either CBD or the placebo. The final weeks of the study will involve assessing changes in alcohol consumption and other health-related factors.

Throughout the study, researchers will monitor various health aspects, including the effects of alcohol on the brain and liver. This will involve looking at changes in brain structure and liver health using methods like MRI (Magnetic Resonance Imaging), which is a type of scan that provides detailed images of the body’s organs. The study aims to provide insights into whether CBD can effectively reduce alcohol consumption and improve health outcomes for individuals with AUD.

]]> Study on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction https://clinicaltrials.eu/trial/study-on-sodium-oxybate-for-reducing-alcohol-consumption-in-patients-with-alcohol-addiction/ Wed, 29 Apr 2026 14:26:44 +0000 https://clinicaltrials.eu/trial/study-on-sodium-oxybate-for-reducing-alcohol-consumption-in-patients-with-alcohol-addiction/ This clinical trial is focused on studying Alcohol Addiction, a condition where individuals have a strong craving for alcohol and find it difficult to control their drinking. The study is testing a treatment called Sodium Oxybate, which is an oral solution that participants will take by mouth. The purpose of the study is to see if Sodium Oxybate can help reduce alcohol consumption and help individuals maintain abstinence, meaning they stop drinking alcohol altogether.

Participants in the study will be individuals who are dependent on alcohol and have a high or very high risk level of drinking. The study will involve taking the medication or a placebo for a period of time, and researchers will monitor the participants’ alcohol consumption. The main goal is to see if there is a reduction in the number of heavy drinking days after three months of treatment.

The study will last for several months, during which participants will have regular visits to check their progress. The researchers aim to gather information on the safety and effectiveness of Sodium Oxybate in helping people with alcohol addiction reduce their drinking and maintain abstinence. This information could be valuable in developing new treatments for alcohol addiction in the future.

]]>